B2B podcasts for agencies: how to productise the offering for healthcare and life sciences in the APAC region
The service design, pricing, and delivery model for running B2B podcasts as a productised offering inside a services firm. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the APAC region.
This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the APAC region. In this market, APAC buyers span very different cultures and reward vendors who adapt playbooks per market, so the way you install B2B podcasts has to be shaped to that reality from day one.
B2B podcasts is one of the highest-margin offerings an agency can add in 2026. It is using a show to earn access to buyers who would ignore a cold email, and clients will pay a premium for the discipline they cannot install themselves.
Productise around outcome, not activity. Sell guest-to-opportunity conversion moving to a defined level in a defined window, not a monthly retainer of vague ops.
Delivery pod: one strategist, one operator, one editor. Fewer people than that risks quality; more than that dilutes margin.
Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the APAC region it is compounded by the fact that market-by-market adaptation, not one-size playbooks is what actually gates growth. B2B podcasts is only useful here when it is pointed at both constraints at once.
Onboarding takes two weeks: diagnosis, list build, trigger definition, kill criteria. Do not ship anything live before the diagnosis is signed off.
Pricing: outcome-linked base plus a monthly ops fee. The base rewards results; the ops fee funds the delivery pod.
Client failure mode: optimising for downloads instead of relationships. Write it into the engagement letter as a shared risk, not something you absorb quietly.
The agencies making the most from B2B podcasts are the ones with the tightest playbook. Documented, versioned, and improved every quarter.
Concretely for healthcare and life sciences in the APAC region: the healthcare teams that install this get past procurement instead of dying in it, and the APAC teams that install this stop treating the region as one market and start winning it as many. That is the reason it is worth installing B2B podcasts deliberately for this market rather than importing a playbook designed for somewhere else.
Frequently asked questions
Content · healthcare · APAC — answered
- Does B2B podcasts work for healthcare and life sciences in the APAC region?
- Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the APAC region, APAC buyers span very different cultures and reward vendors who adapt playbooks per market. The healthcare teams that install this get past procurement instead of dying in it.
- How should agencies price B2B podcasts?
- Outcome-linked base plus a monthly ops fee. Avoid pure retainer.
- What is the minimum delivery pod?
- Strategist, operator, editor. Three roles, not necessarily three headcount at small scale.
- How long is agency onboarding for B2B podcasts?
- Two weeks: diagnosis, list, trigger, kill criteria.
- What client behaviour breaks the engagement?
- Optimising for downloads instead of relationships — bake shared risk into the contract.
- What is the APAC-specific pitfall when running B2B podcasts for healthcare?
- Importing a playbook that was built for another market. In the APAC region, APAC buyers span very different cultures and reward vendors who adapt playbooks per market — the install has to reflect that.
Growth Broker editorial
Filed under content · healthcare · apac